Publicaciones (36) Publicaciones en las que ha participado algún/a investigador/a

2014

  1. Acciones de los fármacos II: dianas y mecanismos moleculares

    Farmacología humana (Elsevier), pp. 16-45

  2. Acute adverse reactions to iopromide vs iomeprol: A retrospective analysis of spontaneous reporting from a radiology department

    British Journal of Radiology, Vol. 87, Núm. 1033

  3. Alcohol-related brain damage in humans

    PLoS ONE, Vol. 9, Núm. 4

  4. Altered neuronal activity and differential sensitivity to acute antidepressants of locus coeruleus and dorsal raphe nucleus in Wistar Kyoto rats: A comparative study with Sprague Dawley and Wistar rats

    European Neuropsychopharmacology, Vol. 24, Núm. 7, pp. 1112-1122

  5. Buspirone anti-dyskinetic effect is correlated with temporal normalization of dysregulated striatal DRD1 signalling in l-DOPA-treated rats

    Neuropharmacology, Vol. 79, pp. 726-737

  6. Combination antifungal therapy: A strategy for the management of invasive fungal infections

    Revista Espanola de Quimioterapia, Vol. 27, Núm. 3, pp. 141-158

  7. Combining rimonabant and fentanyl in a single entity: Preparation and pharmacological results

    Drug Design, Development and Therapy, Vol. 8, pp. 263-277

  8. Correction: Kv7 channels can function without constitutive calmodulin tethering

    PLoS ONE

  9. Cytokine pathway disruption in a mouse model of schizophrenia induced by Munc18-1a overexpression in the brain

    Journal of Neuroinflammation, Vol. 11, Núm. 1

  10. Diferentes propiedades farmacológicas de ketanserina y altanserina sobre los receptores 5-HT2A en cerebro humano postmortem: Interés en estudio de esquizofrenia

    Actualidad en farmacología y terapéutica, Vol. 12, Núm. 1, pp. 59-63

  11. Do post-mortem brain studies provide useful information for Psychiatry?

    Revista de Psiquiatria y Salud Mental, Vol. 7, Núm. 3, pp. 101-103

  12. Evaluation of 5-HT2A and mGlu2/3 receptors in postmortem prefrontal cortex of subjects with major depressive disorder: Effect of antidepressant treatment

    Neuropharmacology, Vol. 86, pp. 311-318

  13. Evaluation of fentanyl disposition and effects in newborn piglets as an experimental model for human neonates

    PLoS ONE, Vol. 9, Núm. 3

  14. FADD adaptor and PEA-15/ERK1/2 partners in major depression and schizophrenia postmortem brains: Basal contents and effects of psychotropic treatments

    Neuroscience, Vol. 277, pp. 541-551

  15. Fast and efficient neural conversion of human hematopoietic cells

    Stem Cell Reports, Vol. 3, Núm. 6, pp. 1118-1131

  16. Fármacos que modifican la actividad simpática

    Farmacología humana (Elsevier), pp. 266-278

  17. Galanin activated Gi/o-proteins in human and rat central nervous systems

    Neuropeptides, Vol. 48, Núm. 5, pp. 295-304

  18. Guanidine-based α2-adrenoceptor ligands: Towards selective antagonist activity

    European Journal of Medicinal Chemistry, Vol. 82, pp. 242-254

  19. High-throughput analysis of lipid hydroperoxides in edible oils and fats using the fluorescent reagent diphenyl-1-pyrenylphosphine

    Food Chemistry, Vol. 162, pp. 235-241

  20. Increased antiparkinson efficacy of the combined administration of VEGF- and GDNF-loaded nanospheres in a partial lesion model of Parkinson's disease

    International Journal of Nanomedicine, Vol. 9, Núm. 1, pp. 2677-2687